Arete Wealth Advisors’s BioCryst Pharmaceuticals BCRX Stock Holding History

Arete Wealth Advisors’s Portfolio BCRX Stock Details BCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$174K	Sell
2025 Q1	$152K	Hold
2024 Q4	$152K	Buy
2024 Q3	$92K	Sell
2024 Q2	$137K	Buy
2024 Q1	–	Sell
2023 Q4	$135K	Sell
2023 Q3	$165K	Buy
2023 Q2	$100K	Sell
2023 Q1	$200K	Buy
2022 Q4	$271M	Buy